Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Pegylated interferon/telbivudine sequential therapy in Hepatitis Be antigen negative severe chronic hepatitis B patient.

Caroleo B, Staltari O, Gallelli L, Guadagnino V.

J Res Med Sci. 2013 Apr;18(4):368-9. No abstract available.

2.

Multiple abscesses of the left brain hemisphere due to Listeria monocytogenes in an immunocompromised patient: a case report.

Matera G, Puccio R, Giancotti A, Quirino A, Guadagnino V, Pardatscher K, Caroleo S, De Rose M, Amorosi A, Liberto MC, Focà A.

Infez Med. 2012 Dec;20(4):279-83.

3.

Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection.

Guadagnino V, Stroffolini T, Caroleo B, Menniti Ippolito F, Rapicetta M, Ciccaglione AR, Chionne P, Madonna E, Costantino A, De Sarro G, Focà A, Lentini M, Staltari O; Sersale's Study Group.

Dig Liver Dis. 2013 May;45(5):403-7. doi: 10.1016/j.dld.2012.10.014. Epub 2012 Nov 28.

PMID:
23199596
4.

Natural history and clinical response: "it's the virus, stupid, or is it the host?".

Nucara S, Caroleo B, Guadagnino V, Perrotti N, Trapasso F.

BMC Infect Dis. 2012;12 Suppl 2:S6. doi: 10.1186/1471-2334-12-S2-S6. Epub 2012 Nov 12. Review.

5.

The impact of a vaccination campaign against hepatitis B on the further decrease of hepatitis B virus infection in a southern Italian town over 14 years.

Stroffolini T, Guadagnino V, Rapicetta M, Menniti Ippolito F, Caroleo B, De Sarro G, Focà A, Liberto MC, Giancotti A, Barreca GS, Marascio N, Lombardo F, Staltari O; Sersale's Study Collaborating Group.

Eur J Intern Med. 2012 Dec;23(8):e190-2. doi: 10.1016/j.ejim.2012.08.009. Epub 2012 Sep 13.

PMID:
22981290
6.

Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town.

Stroffolini T, Guadagnino V, Caroleo B, De Sarro G, Focà A, Liberto MC, Giancotti A, Barreca GS, Marascio N, Lombardo FL, Staltari O; “Sersale’s Study” Group.

Infection. 2012 Jun;40(3):299-302. doi: 10.1007/s15010-011-0233-2. Epub 2011 Dec 16.

PMID:
22173948
7.

Muscular damage during telbivudine treatment in a chronic hepatitis B patient.

Caroleo B, Galasso O, Staltari O, Giofrè C, De Sarro G, Guadagnino V, Gallelli L.

Muscles Ligaments Tendons J. 2011 Dec 29;1(2):57-60. Print 2011 Apr.

8.

May phylogenetic analysis support epidemiological investigation in identifying the source of HIV infection?

Ciccozzi M, Lo Presti A, Cenci A, Staltari O, Buttò S, Equestre M, Ciccaglione AR, Caroleo B, Rezza G, Guadagnino V.

AIDS Res Hum Retroviruses. 2011 May;27(5):455-7. doi: 10.1089/aid.2010.0189. Epub 2010 Oct 23. No abstract available.

PMID:
20969458
9.

Current practice of hepatitis C treatment in Southern Italy.

Stroffolini T, Spadaro A, Guadagnino V, Cosentino S, Fatuzzo F, Galdieri A, Cacopardo B, Scalisi I, Sapienza M, Russello M, Scifo G, Frugiuele P, Foti G, Almasio PL; Gr.E.Ca.S. Hospitals’ Collaborating Group.

Dig Liver Dis. 2010 Nov;42(11):822-5. doi: 10.1016/j.dld.2010.03.020.

PMID:
20435532
10.

Comment to "Treating chronic hepatitis C in recovering opiate addicts: yes, we can".

Guadagnino V.

Dig Liver Dis. 2010 Apr;42(4):305; author reply 305-6. doi: 10.1016/j.dld.2009.07.013. Epub 2009 Aug 25. No abstract available.

PMID:
19709937
11.

Serum transaminase elevations during pegylated interferon treatment of chronic HCV hepatitis probably induced by polyethylene glycol.

Caroleo B, Gallelli L, Staltari O, De Sarro G, Guadagnino V.

Intervirology. 2008;51(6):407-9. doi: 10.1159/000205266. Epub 2009 Mar 4.

PMID:
19258719
12.

Prophylaxis of hepatitis C with intramuscular immunoglobulin: clinical and economic appraisal.

Piazza M, Sagliocca L, Tosone G, Guadagnino V, Stazi MA, Orlando R, Borgia G, Rosa D, Abrignani S, Palumbo F, Manzin A, Clementi M.

BioDrugs. 1999 Oct;12(4):291-300.

PMID:
18031183
13.

Bilateral Skin Ulceration after Injection of Pegylated Interferon-alpha-2b in a Patient with Chronic Hepatitis C.

Gallelli L, Guadagnino V, Caroleo B, Marigliano N, De Sarro GB, Izzi A.

Clin Drug Investig. 2003;23(9):615-9. No abstract available.

PMID:
17535076
14.

Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes.

Guadagnino V, Trotta MP, Montesano F, Babudieri S, Caroleo B, Armignacco O, Carioti J, Maio G, Monarca R, Antinori A; Nocchiero Study Group.

Addiction. 2007 Mar;102(3):423-31.

PMID:
17298650
15.

An unusual case of brain abscess by Gemella morbillorum.

Liberto MC, Matera G, Puccio R, Barbieri V, Quirino A, Capicotto R, Guadagnino V, Pardatscher K, Focà A.

Jpn J Infect Dis. 2006 Apr;59(2):126-8.

16.

Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients.

Taliani G, Gemignani G, Ferrari C, Aceti A, Bartolozzi D, Blanc PL, Capanni M, Esperti F, Forte P, Guadagnino V, Mari T, Marino N, Milani S, Pasquazzi C, Rosina F, Tacconi D, Toti M, Zignego AL, Messerini L, Stroffolini T; Nonresponder Retreatment Group.

Gastroenterology. 2006 Apr;130(4):1098-106.

PMID:
16618404
17.

Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users?

Guadagnino V, Trotta MP, Carioti J, Caroleo B, Antinori A; Nocchiero Study Group.

Dig Liver Dis. 2006 Feb;38(2):119-24. Epub 2005 Nov 16.

PMID:
16297672
18.

A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C.

Mangia A, Ricci GL, Persico M, Minerva N, Carretta V, Bacca D, Cela M, Piattelli M, Annese M, Maio G, Conte D, Guadagnino V, Pazienza V, Festi D, Spirito F, Andriulli A.

J Viral Hepat. 2005 May;12(3):292-9.

PMID:
15850470
19.

Sexual transmission of hepatitis C virus and prevention with intramuscular immunoglobulin.

Piazza M, Sagliocca L, Tosone G, Guadagnino V, Stazi MA, Orlando R, Borgia G, Rosa D, Abrignani S, Palumbo F, Manzin A, Clementi M.

AIDS Patient Care STDS. 1998 Aug;12(8):611-8.

PMID:
15468432
20.

Differences between semen and plasma of nucleoside reverse transcriptase resistance mutations in HIV-infected patients, using a rapid assay.

Liuzzi G, Chirianni A, Zaccarelli M, Zinzi D, Esposito V, Guadagnino V, Antinori A, Piazza M.

In Vivo. 2004 Jul-Aug;18(4):509-12.

Supplemental Content

Loading ...
Support Center